ALACHUA, Fla., Aug. 29 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc.
(Amex: TTG), a leading manufacturer of sterile biological implant products
made from human (allograft) and animal (xenograft) tissue, announced today
that Guy L. Mayer, President and Chief Executive Officer, will be
presenting at the Roth Capital Partners New York Investor Conference on
Thursday, September 6, 2007 at 9:30 a.m. Eastern time. The conference is
being held at The Westin NY at Times Square, 270 West 43rd Street, New
York, NY.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products
made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes
its proprietary Tutoplast Process(R) of tissue preservation and viral
inactivation to manufacture and deliver sterile bio-implants used in
spinal/trauma, urology, dental, ophthalmology, and general surgery
procedures. The Company's Tutoplast(R) products are sold and distributed
worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer
Holdings, Inc., Davol Inc. subsidiary of C.R. Bard Inc., the Mentor
Corporation (Mentor), Coloplast Corp., IOP, Inc. and through independent
distributors internationally. For more information, visit the Company's Web
site at http://www.tutogen.com.
Forward-Looking Statement Disclaimer:
This press release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements typically are identified by use of terms such as
"may," "will," "should," "plan," "expect," "anticipate," "estimate," and
similar words, although some forward-looking statements are expressed
differently. Forward-looking statements are based on management's current
expectations and are subject to certain risks and uncertainties that could
cause actual results to differ materially from those set forth or implied
by forward-looking statements. These and other risks are identified in the
Company's filings with the Securities and Exchange Commission, including
the Company's Annual Report on Form 10-K for the fiscal year ended
September 30, 2006. All information in this press release is as of the date
hereof, and the Company undertakes no duty to update this information
unless required by law.
Contacts:
L. Robert Johnston, Jr. Lytham Partners, LLC
Chief Financial Officer Joe Diaz
Tutogen Medical, Inc. Joe Dorame
386-462-0402 Robert Blum
bjohnston@tutogen.com 602-889-9700
SOURCE Tutogen Medical, Inc.
 back to top
Related links:
http://www.tutogen.com
CONTACT:
L. Robert Johnston, Jr., Chief Financial
Officer of Tutogen Medical, Inc., +1-386-462-0402,
bjohnston@tutogen.com; or Joe Diaz, Joe Dorame or Robert Blum,
all of Lytham Partners, LLC, +1-602-889-9700, for Tutogen
Medical, Inc.
|
